The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Autor: L Bartalena, G J Kahaly, L Baldeschi, C M Dayan, A Eckstein, C Marcocci, M Marinò, B Vaidya, W M Wiersinga, Goksun Ayvaz, Onur Konuk, Jasmina Ciric, Bijliana Beleslin, Antonella Boschi, Maria Cristina Burlacu, Dan Morris, Rosario Le Moli, Antonio Marino, Justin McKee, Nicola Zammit, Dagmar Führer, Ioana Pereni, Michael Schittkowski, Dirk Raddatz, Vickie Lee, Karim Meeran, Juliette Abeillon, Thia Soui Thcong, Katharina Ponto, Ilaria Muller, Nicola Currò, Christoph Hintschich, Roland Gärtner, Simon Pearce, Lucy Clarke, Thomas Brix, Dorte Bechtold, Gottfried Rudovfsky, Nicole Fichter, Laurence Du Pasquier, Julia Meney, Francesca Menconi, Giulia Lanzolla, Gangadhara Sundar, Samantha Peiling Yung, Kostas Boboridis, Panagiotis Anagnostis, Marta Pérez Lopez, Carlos Javier Sanchez, Maria Laura Tanda, Simone Donati, Andrea Papp, Shuren Li, Anna Jablonska, Piotr Miskiewicz, Jelena Juri Mandic, Maja Baretic

Publikováno v: European journal of endocrinology, Vol. 185, no. 4, p. G43-G67 (2021)
European Journal of Endocrinology, 185(4), G43-G67. BioScientifica Ltd.

Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Choice of treatment should be based on the assessment of clinical activity and severity of GO. Early referral to specialized centers is fundamental for mos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71629229c4ad08577973ef207b8d40a5
https://doi.org/10.1530/eje-21-0479